JP2018534910A5 - - Google Patents

Download PDF

Info

Publication number
JP2018534910A5
JP2018534910A5 JP2018512289A JP2018512289A JP2018534910A5 JP 2018534910 A5 JP2018534910 A5 JP 2018534910A5 JP 2018512289 A JP2018512289 A JP 2018512289A JP 2018512289 A JP2018512289 A JP 2018512289A JP 2018534910 A5 JP2018534910 A5 JP 2018534910A5
Authority
JP
Japan
Prior art keywords
cells
seq
methylation
region
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018512289A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018534910A (ja
Filing date
Publication date
Priority claimed from GBGB1516971.7A external-priority patent/GB201516971D0/en
Application filed filed Critical
Publication of JP2018534910A publication Critical patent/JP2018534910A/ja
Publication of JP2018534910A5 publication Critical patent/JP2018534910A5/ja
Pending legal-status Critical Current

Links

JP2018512289A 2015-09-25 2016-09-22 免疫細胞、特にcd56+ nk細胞の同定のためのエピジェネティックマーカーとしてのmvd Pending JP2018534910A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1516971.7 2015-09-25
GBGB1516971.7A GB201516971D0 (en) 2015-09-25 2015-09-25 MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells
PCT/EP2016/072522 WO2017050882A1 (en) 2015-09-25 2016-09-22 Mvd as epigenetic marker for the identification of immune cells, in particular cd56+ nk cells

Publications (2)

Publication Number Publication Date
JP2018534910A JP2018534910A (ja) 2018-11-29
JP2018534910A5 true JP2018534910A5 (enExample) 2019-10-31

Family

ID=54544101

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018512289A Pending JP2018534910A (ja) 2015-09-25 2016-09-22 免疫細胞、特にcd56+ nk細胞の同定のためのエピジェネティックマーカーとしてのmvd

Country Status (8)

Country Link
US (1) US11788141B2 (enExample)
EP (1) EP3353321B1 (enExample)
JP (1) JP2018534910A (enExample)
CN (1) CN108026577B (enExample)
CA (1) CA2995350A1 (enExample)
GB (1) GB201516971D0 (enExample)
HK (1) HK1257705A1 (enExample)
WO (1) WO2017050882A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102017125013B4 (de) * 2017-10-25 2019-10-17 Epiontis Gmbh MCC als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere basophiler Granulozyten
DE102018112644B4 (de) 2018-05-25 2020-06-10 Epiontis Gmbh CXCR3 als epigenetischer Marker zur Identifizierung von inflammatorischen Immunzellen, insbesondere CD8+ Gedächnis-T-Zellen
DE102018116353B4 (de) 2018-07-05 2020-06-10 Epiontis Gmbh Verfahren zum Nachweis und zur Zählung epigenetischer Immunzellen in humanen Blutproben für Immundiagnostik und Neugeborenen-Screening
CN119372341B (zh) * 2024-12-30 2025-04-11 北京致谱医学检验实验室有限公司 基于基因甲基化检测实现人nk淋巴细胞计数的试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH2220H1 (en) * 2001-08-10 2008-07-01 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
ATE508207T1 (de) * 2006-02-28 2011-05-15 Charite Universitaetsmedizin Nachweis und qualitätskontrolle von regulator-t- zellen mittels dna-methylierungsanalyse des foxp3-gens
WO2010006215A1 (en) * 2008-07-09 2010-01-14 Celera Corporation Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
EP2248913B1 (en) * 2009-04-28 2016-10-05 Epiontis GmbH GNLY as epigenetic marker for the identification of CD56-expressing natural killer cells
CN102343086A (zh) * 2010-05-28 2012-02-08 四川大学 治疗或预防肿瘤的药物、肿瘤全细胞疫苗及其制备方法和用途
WO2012045888A1 (en) * 2010-10-08 2012-04-12 Epiontis Gmbh Method for determining cancer patient survival based on analyzing tumor-infiltrating overall t-lymphocytes
GB201112586D0 (en) 2011-07-22 2011-09-07 Epiontis Gmbh Epigenetic marker for the identification of natural killer cells
US20130129668A1 (en) * 2011-09-01 2013-05-23 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics

Similar Documents

Publication Publication Date Title
Witkowski et al. Extensive remodeling of the immune microenvironment in B cell acute lymphoblastic leukemia
Cetica et al. Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry
Jara-Acevedo et al. Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications
EP3561074B1 (en) Method for identifying the quantitative cellular composition in a biological sample
Halbritter et al. Epigenomics and single-cell sequencing define a developmental hierarchy in Langerhans cell histiocytosis
Martino et al. Evidence for age-related and individual-specific changes in DNA methylation profile of mononuclear cells during early immune development in humans
JP2018529345A5 (enExample)
CN109906381B (zh) 鉴别、靶向以及分离人树突细胞(dc)前体“前dc”的方法及其用途
JP2024054311A (ja) 血液中の無細胞dnaを用いた血液学的障害の検出
JP2012511917A5 (enExample)
Bhandari et al. Transcriptome and proteome profiling reveal complementary scavenger and immune features of rat liver sinusoidal endothelial cells and liver macrophages
JP2018529346A5 (enExample)
Guarrera et al. Peripheral blood DNA methylation as potential biomarker of malignant pleural mesothelioma in asbestos-exposed subjects
JP2018534910A5 (enExample)
Schulte-Schrepping et al. Suppressive myeloid cells are a hallmark of severe COVID-19
EP1913387A1 (en) Method for identifying regulatory t cells
HK1257122A1 (zh) Lrp5作为用於鉴定免疫细胞特别是b细胞的表观遗传标志物
US20200270683A1 (en) Methods for obtaining embryonic stem cell dna methylation signatures
CN103911439A (zh) 系统性红斑狼疮羟甲基化状态的差异表达基因的分析方法和应用
Genshaft et al. Clinical implementation of single-cell RNA sequencing using liver fine needle aspirate tissue sampling and centralized processing captures compartment specific immuno-diversity
JP6113159B2 (ja) ナチュラルキラー細胞を同定するエピジェネティックマーカー
JP2021502806A5 (enExample)
CN118553310A (zh) 器官移植免疫功能评价和免疫衰老评估指标的免疫组库
Szántó et al. Real-time quantitative PCR detection of WT1 and M-BCR-ABL expressions in chronic myeloid leukemia
JP2021502809A5 (enExample)